Promoter‐Controlled Synthesis and Conformational Analysis of Cyclic Mannosides up to a 32‐mer

Author:

Li Xiaona1,Di Carluccio Cristina2,Miao He1,Zhang Lvfeng1,Shang Jintao1,Molinaro Antonio23,Xu Peng4,Silipo Alba23,Yu Biao4,Yang You1ORCID

Affiliation:

1. Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism Shanghai Key Laboratory of New Drug Design Engineering Research Center of Pharmaceutical Process Chemistry Ministry of Education School of Pharmacy East China University of Science and Technology 130 Meilong Road Shanghai 200237 China

2. Department of Chemical Sciences University of Naples Federico II Via Cintia 4 80126 Napoli Italy

3. Department of Chemistry School of Science Osaka University 1-1 Osaka University Machikaneyama Toyonaka Osaka 560-0043 Japan

4. State Key Laboratory of Bioorganic and Natural Products Chemistry Shanghai Institute of Organic Chemistry Chinese Academy of Sciences 345 Lingling Road Shanghai 200032 China

Abstract

AbstractCyclodextrins are widely used as carriers of small molecules for drug delivery owing to their remarkable host properties and excellent biocompatibility. However, cyclic oligosaccharides with different sizes and shapes are limited. Cycloglycosylation of ultra‐large bifunctional saccharide precursors is challenging due to the constrained conformational spaces. Herein we report a promoter‐controlled cycloglycosylation approach for the synthesis of cyclic α‐(1→6)‐linked mannosides up to a 32‐mer. Cycloglycosylation of the bifunctional thioglycosides and (Z)‐ynenoates was found to be highly dependent on the promoters. In particular, a sufficient amount of a gold(I) complex played a key role in the proper preorganization of the ultra‐large cyclic transition state, providing a cyclic 32‐mer polymannoside, which represents the largest synthetic cyclic polysaccharide to date. NMR experiments and a computational study revealed that the cyclic 2‐mer, 4‐mer, 8‐mer, 16‐mer, and 32‐mer mannosides adopted different conformational states and shapes.

Funder

National Natural Science Foundation of China

Youth Innovation Promotion Association of the Chinese Academy of Sciences

Opening Project of Shanghai Key Laboratory of New Drug Design

Publisher

Wiley

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3